NAC has been shown to decrease the frequency and severity of Raynaud’s phenomenon (RP) attacks and digital ulcers (DU) in patients with systemic sclerosis (SSc), with a significant reduction in plasma adrenomedullin concentrations [11,12,13]. Here, ADM is linked to systemic sclerosis.